Data / Form D filings / TETRALOGIC PHARMACEUTICALS CORP
TETRALOGIC PHARMACEUTICALS CORP: Form D filings
TETRALOGIC PHARMACEUTICALS CORP, a pharmaceuticals company in Malvern, PA, filed 6 Form D notices with the SEC between 2010 and 2012. The latest, on December 13, 2012, reports $5 million sold of a $10 million offering to 21 investors.
Find out what TETRALOGIC PHARMACEUTICALS CORP does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 343 PHOENIXVILLE PIKE, Malvern, PA, 19355
- Phone
- (610) 889-9900
- Industry
- Pharmaceuticals
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506
- SEC identifier (CIK)
- 1361248
The full lists. Form D filings in Pennsylvania: 987 rows, $49.35, or the new rows each week for $19 a month. Form D filings in Pharmaceuticals: 346 rows, $17.30, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Dec 13, 2012 | New notice | $10,000,000 | $5,000,000 | $5,000,000 | 21 | Nov 29, 2012 | sec.gov |
| May 31, 2011 | New notice | $5,999,734 | $5,999,734 | $0 | 2 | May 20, 2011 | sec.gov |
| Aug 10, 2010 | New notice | $32,000,000 | $12,496,000 | $19,504,000 | 10 | Jul 26, 2010 | sec.gov |
| Mar 24, 2010 | New notice | $2,400,000 | $2,400,000 | $0 | 13 | Mar 11, 2010 | sec.gov |
| Mar 24, 2010 | Amendment | $2,000,000 | $2,000,000 | $0 | 13 | Nov 25, 2009 | sec.gov |
| Mar 9, 2010 | New notice | $2,000,000 | $2,000,000 | $0 | 13 | Nov 25, 2009 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| John M. Gill | Executive Officer, Director | |
| Brenda E. Gavin | Director | |
| James E. Goldschmidt | Executive Officer | |
| David E. Weng | Executive Officer | |
| Andrew E. Pecora | Director | |
| Douglas E. Onsi | Director | |
| Michael E. Steinmetz | Director | |
| Paul E. Schmitt | Director | |
| James E. Woody | Director | |
| Douglas E. Reed | Director |
Other pharmaceuticals companies in Pennsylvania that filed recently
- Telemachus Therapeutics, Inc. $375,000 · Oct 28, 2026
- EpiVario Inc. $185,000 · Oct 13, 2026
- Maxona Pharmaceuticals, Inc. $5.8 million · Aug 14, 2026
Every Form D from the week of Dec 10, 2012 · All recent filings in Pennsylvania · All recent Pharmaceuticals filings
Read from SEC EDGAR. Amount sold is what TETRALOGIC PHARMACEUTICALS CORP reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.